It will therefore be informative to further investigate molecular signaling pathways and mechanistic details of DRAK2 mediated action in CLL to completely validate as a target for monitoring CLL pathogenesis and progression. The gene discussed is STK17B; the disease is B-cell chronic lymphocytic leukemia.